NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 10 percent increase in second quarter revenues, resulting from growth in all of its business segments, in particular analytical instruments.

"We had another excellent quarter," said President and CEO Marc Casper in a conference call this morning to discuss the company's earnings. "Our performance in Q2 contributed to a strong first half and we’re right on track to deliver another great year."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.